Mercado Livre Launches Prescription Medication Sales in Brazil with Rapid Delivery Service
Mercado Livre has begun selling prescription medications in São Paulo, Brazil, with rapid delivery services amid legal challenges.
- • Mercado Livre launched prescription medication sales in São Paulo on September 25, including antibiotics and GLP-1 drugs like Ozempic.
- • Customers must upload prescriptions for pharmacist validation before purchase approval.
- • The company introduced 'Envios Agora,' a delivery service promising one-hour delivery for some products.
- • Abrafarma plans to challenge the legality of Mercado Livre's prescription sales with Anvisa.
- • Mercado Livre is expanding logistics with 20 new operations and supporting small businesses with credit and AI tools.
Key details
Mercado Livre officially launched the sale of prescription medications in Brazil on September 25, starting in São Paulo, marking a significant expansion of its marketplace offerings into the pharmaceutical sector. The initial product selection includes antibiotics and GLP-1 medications such as Ozempic and Wegovy, addressing growing consumer demand identified during a pilot that began in March with non-prescription drugs.
Customers purchasing prescription drugs on Mercado Livre must upload their prescriptions online, which are then validated by qualified pharmacists before approval. The company is operating its own pharmacy initially, with plans to integrate partner pharmacies by October, expanding the reach of this new service.
Complementing the launch is Mercado Livre's new logistics innovation, the delivery service "Envios Agora," which promises to deliver orders within one hour for certain products. This fast delivery model positions Mercado Livre in direct competition with established services like iFood. Additionally, the company announced a broader logistics expansion with 20 new operations planned this year, boosting its total logistical centers by 39% to 72 units.
The Brazilian Association of Pharmacies and Drugstores (Abrafarma) has challenged Mercado Livre's move, signaling its intention to contest the legality of selling prescription medications through online marketplaces to Brazil's National Health Surveillance Agency (Anvisa). Abrafarma argues that such sales remain prohibited until regulatory frameworks are finalized, reflecting ongoing regulatory tensions.
Beyond pharmacy sales, Mercado Livre is enhancing its support for small businesses by introducing new credit options, such as interest-free credit for up to seven days, and expanding artificial intelligence tools designed to assist sellers. This holistic strategy aims to transform Mercado Livre into a full ecosystem supporting small business operations across inventory, advertising, and customer service.
This launch represents Mercado Livre's latest move to integrate pharmaceutical retail within its expansive e-commerce and logistics infrastructure across Latin America, following established operations in Mexico, Colombia, Argentina, and Chile. As Brazil’s demand for convenient access to medications grows, Mercado Livre’s delivery and sales innovation could significantly reshape the market, pending regulatory approval and competitive responses.
This article was translated and synthesized from Brazilian sources, providing English-speaking readers with local perspectives.